G protein-coupled receptors (GPCRs), the largest cell surface receptor superfamily, are activated by diverse ligands to couple with G proteins and trigger signaling cascades, serving as critical therapeutic targets for lipid metabolism disorders including obesity and NAFLD [49,50]. This evidence concerns the gene CD177 and obesity disorder.